Outset Medical (OM) Price to Sales (2020 - 2026)

Outset Medical (OM) has reported Price to Sales for 7 consecutive years, with 2.57 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 76.37% year-over-year to 2.57 in Q2 2026; TTM through Jun 2026 was 0.69, a 75.9% decrease from a year earlier, with the FY2025 full-year figure at 0.56, up 9.14% from the prior year.
• Price to Sales was 2.57 for Q2 2026 at Outset Medical, up from 2.55 in the prior quarter.
• Over five years, Price to Sales peaked at 70.91 in Q1 2022 and troughed at 1.24 in Q3 2024.
• A 5-year average of 16.35 and a median of 8.73 in 2025 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 93.1% in 2024 and soared 588.58% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 39.1 in 2022, then plunged by 77.18% to 8.92 in 2023, then sank by 77.65% to 1.99 in 2024, then gained by 17.05% to 2.33 in 2025, then increased by 9.95% to 2.57 in 2026.
• The last three Price to Sales figures came in at 2.57 (Q2 2026), 2.55 (Q1 2026), and 2.33 (Q4 2025), per Business Quant data.